| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft vs Host Disease | 25 | 2023 | 163 | 13.490 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 14 | 2023 | 245 | 6.870 |
Why?
|
| T-Lymphocytes | 14 | 2022 | 597 | 4.100 |
Why?
|
| Leukemia | 5 | 2022 | 117 | 3.040 |
Why?
|
| Graft vs Leukemia Effect | 10 | 2022 | 33 | 2.970 |
Why?
|
| Bone Marrow Transplantation | 6 | 2023 | 149 | 2.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2022 | 266 | 1.590 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2020 | 199 | 1.580 |
Why?
|
| MicroRNAs | 5 | 2022 | 447 | 1.550 |
Why?
|
| Transplantation, Homologous | 9 | 2023 | 242 | 1.510 |
Why?
|
| Lymphocyte Activation | 9 | 2021 | 397 | 1.490 |
Why?
|
| Mice | 28 | 2023 | 8474 | 1.430 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2021 | 16 | 1.400 |
Why?
|
| Th17 Cells | 7 | 2018 | 116 | 1.360 |
Why?
|
| Mice, Knockout | 14 | 2022 | 1692 | 1.360 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 40 | 1.250 |
Why?
|
| Th1 Cells | 4 | 2018 | 101 | 1.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2022 | 226 | 1.210 |
Why?
|
| Animals | 32 | 2023 | 20881 | 1.110 |
Why?
|
| Mice, Inbred BALB C | 9 | 2021 | 532 | 1.070 |
Why?
|
| T-Box Domain Proteins | 2 | 2016 | 29 | 1.030 |
Why?
|
| Hematologic Neoplasms | 2 | 2022 | 37 | 0.950 |
Why?
|
| Intestines | 2 | 2023 | 114 | 0.930 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 329 | 0.920 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 2791 | 0.870 |
Why?
|
| Interleukin-12 | 3 | 2021 | 75 | 0.860 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2019 | 132 | 0.860 |
Why?
|
| Clonal Selection, Antigen-Mediated | 1 | 2021 | 2 | 0.810 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2021 | 5 | 0.810 |
Why?
|
| Lymphoid Tissue | 1 | 2021 | 30 | 0.800 |
Why?
|
| Interleukin-17 | 3 | 2016 | 62 | 0.790 |
Why?
|
| Endoribonucleases | 1 | 2021 | 22 | 0.780 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 22 | 0.770 |
Why?
|
| Proteolysis | 1 | 2021 | 97 | 0.760 |
Why?
|
| Bacteroides fragilis | 1 | 2021 | 20 | 0.760 |
Why?
|
| Interleukins | 1 | 2021 | 79 | 0.750 |
Why?
|
| Sterol Esterase | 1 | 2020 | 5 | 0.750 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 50 | 0.750 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 135 | 0.730 |
Why?
|
| Th2 Cells | 2 | 2018 | 48 | 0.730 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.710 |
Why?
|
| Membrane Proteins | 2 | 2022 | 617 | 0.700 |
Why?
|
| Interferon-gamma | 3 | 2016 | 241 | 0.690 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1034 | 0.680 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.670 |
Why?
|
| Receptors, Cytokine | 1 | 2019 | 19 | 0.670 |
Why?
|
| Allografts | 4 | 2021 | 63 | 0.670 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 41 | 0.660 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 122 | 0.660 |
Why?
|
| Complement Activation | 1 | 2020 | 145 | 0.630 |
Why?
|
| Complement System Proteins | 1 | 2020 | 135 | 0.630 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2018 | 4 | 0.620 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 3 | 0.620 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2018 | 15 | 0.620 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 94 | 0.620 |
Why?
|
| Plasma Cells | 1 | 2018 | 19 | 0.620 |
Why?
|
| Scleroderma, Diffuse | 1 | 2018 | 25 | 0.610 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2550 | 0.600 |
Why?
|
| H-Y Antigen | 1 | 2015 | 1 | 0.520 |
Why?
|
| Leukemia, Experimental | 1 | 2015 | 14 | 0.510 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 4 | 0.510 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 217 | 0.500 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 46 | 0.500 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 40 | 0.490 |
Why?
|
| Pyrazoles | 1 | 2015 | 190 | 0.470 |
Why?
|
| Pyrimidines | 1 | 2015 | 178 | 0.470 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 116 | 0.460 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 1033 | 0.450 |
Why?
|
| Macrophages | 3 | 2021 | 647 | 0.390 |
Why?
|
| Humans | 23 | 2022 | 68618 | 0.380 |
Why?
|
| Dendritic Cells | 3 | 2020 | 201 | 0.370 |
Why?
|
| Whole-Body Irradiation | 2 | 2021 | 52 | 0.330 |
Why?
|
| Gene Expression | 3 | 2016 | 770 | 0.320 |
Why?
|
| Mice, Inbred DBA | 2 | 2021 | 120 | 0.310 |
Why?
|
| Acute Disease | 2 | 2023 | 658 | 0.310 |
Why?
|
| Ceramides | 2 | 2022 | 578 | 0.300 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 304 | 0.290 |
Why?
|
| Cytokines | 3 | 2016 | 866 | 0.280 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2018 | 87 | 0.270 |
Why?
|
| Neoplasms | 4 | 2020 | 1667 | 0.260 |
Why?
|
| Histocompatibility Testing | 2 | 2015 | 38 | 0.250 |
Why?
|
| Signal Transduction | 5 | 2021 | 2689 | 0.230 |
Why?
|
| Friend murine leukemia virus | 1 | 2022 | 10 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 852 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2022 | 17 | 0.210 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 46 | 0.210 |
Why?
|
| Immune Tolerance | 3 | 2018 | 114 | 0.200 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 19 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2022 | 117 | 0.200 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Pancreas | 1 | 2023 | 225 | 0.200 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 138 | 0.200 |
Why?
|
| Interleukin-23 | 1 | 2021 | 13 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 68 | 0.190 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 22 | 0.190 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 48 | 0.190 |
Why?
|
| Mice, SCID | 2 | 2021 | 238 | 0.190 |
Why?
|
| Virulence | 1 | 2021 | 51 | 0.190 |
Why?
|
| Hypoxia | 1 | 2022 | 169 | 0.190 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 17 | 0.190 |
Why?
|
| Isoantigens | 1 | 2021 | 26 | 0.190 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 99 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 247 | 0.190 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 157 | 0.190 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1664 | 0.180 |
Why?
|
| Phenotype | 2 | 2021 | 947 | 0.180 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.180 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
| Prognosis | 3 | 2021 | 2093 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 191 | 0.180 |
Why?
|
| Complement Pathway, Classical | 1 | 2020 | 22 | 0.180 |
Why?
|
| Immunophenotyping | 1 | 2020 | 110 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 756 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 22 | 0.170 |
Why?
|
| Recurrence | 1 | 2022 | 948 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 332 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 126 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 179 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2019 | 95 | 0.160 |
Why?
|
| Thiazolidines | 1 | 2018 | 23 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 95 | 0.160 |
Why?
|
| Immunotherapy | 2 | 2017 | 215 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2022 | 753 | 0.160 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 132 | 0.160 |
Why?
|
| Germinal Center | 1 | 2018 | 13 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 118 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 184 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2018 | 93 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 87 | 0.150 |
Why?
|
| Models, Animal | 1 | 2019 | 252 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 201 | 0.150 |
Why?
|
| Skin Transplantation | 1 | 2018 | 45 | 0.150 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Glycolysis | 1 | 2018 | 79 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 65 | 0.150 |
Why?
|
| Sphingosine | 1 | 2019 | 315 | 0.150 |
Why?
|
| NAD | 1 | 2017 | 73 | 0.140 |
Why?
|
| Male | 8 | 2021 | 37321 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2021 | 1330 | 0.140 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 508 | 0.140 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.140 |
Why?
|
| Mitochondria | 1 | 2021 | 643 | 0.130 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 19 | 0.130 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 65 | 0.130 |
Why?
|
| Adenine | 1 | 2015 | 46 | 0.130 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 94 | 0.130 |
Why?
|
| Oligonucleotides | 1 | 2015 | 34 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2018 | 434 | 0.130 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 34 | 0.130 |
Why?
|
| Epidermis | 1 | 2015 | 42 | 0.130 |
Why?
|
| Spleen | 1 | 2016 | 301 | 0.130 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 114 | 0.130 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 56 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2015 | 68 | 0.120 |
Why?
|
| Aging | 1 | 2021 | 911 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2015 | 24 | 0.120 |
Why?
|
| Receptors, Interferon | 1 | 2014 | 8 | 0.120 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 7 | 0.120 |
Why?
|
| Piperidines | 1 | 2015 | 123 | 0.120 |
Why?
|
| Psoriasis | 1 | 2015 | 46 | 0.120 |
Why?
|
| Granzymes | 1 | 2014 | 19 | 0.120 |
Why?
|
| Receptors, CXCR3 | 1 | 2014 | 16 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2015 | 37 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 195 | 0.120 |
Why?
|
| 5'-Nucleotidase | 1 | 2014 | 13 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 77 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2015 | 57 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 88 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2016 | 195 | 0.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 133 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1174 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 167 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 213 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2015 | 714 | 0.110 |
Why?
|
| Time Factors | 1 | 2021 | 4655 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 163 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 682 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2015 | 432 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1293 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 334 | 0.100 |
Why?
|
| Sex Factors | 1 | 2015 | 1266 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 2176 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 91 | 0.090 |
Why?
|
| Liver | 1 | 2016 | 1118 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 710 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 1851 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2015 | 489 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2015 | 954 | 0.060 |
Why?
|
| Carcinogenesis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Mesoderm | 1 | 2023 | 231 | 0.050 |
Why?
|
| Karyopherins | 1 | 2021 | 11 | 0.050 |
Why?
|
| DNA, Ribosomal | 1 | 2021 | 59 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 55 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 235 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 291 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 150 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 90 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 369 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 546 | 0.040 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2019 | 63 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 902 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 241 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.040 |
Why?
|
| Glutamine | 1 | 2017 | 45 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2017 | 47 | 0.040 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2016 | 9 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 700 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 68 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2015 | 7 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2016 | 75 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 52 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2015 | 89 | 0.030 |
Why?
|
| Apyrase | 1 | 2014 | 10 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 27 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 266 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 324 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 536 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 244 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2014 | 134 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 230 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 792 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 130 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2014 | 144 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1174 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 384 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 21147 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2673 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7029 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4848 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 5717 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 7277 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14862 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 21403 | 0.010 |
Why?
|